RESEARCH BASE

Search 3,721 documents across 34 fields — every claim tier-rated by evidence

3,721 Documents 34 Sections 43,625 Citations 34,852 Keywords Indexed 4 Evidence Tiers

3,633 are the core, quality-scored corpus (34 lettered sections — see How We Work); the remaining 88 are cross-corpus synthesis documents (68 InterDocs, 12 Connections, 8 Theories) also indexed here.

2,233 results for "Z boson" — page 16 of 112

Z_2_13 Verified Molecular Biology

Z_2_13 — Pharmacogenomics and Personalized Medicine

Pharmacogenomics — the study of how genetic variation influences drug response — is among the most clinically actionable applications of human genetics. Adverse drug reactions (ADRs) are the 4th–6th leading cause of deat

pharmacogenomics pharmacogenetics personalized medicine precision medicine CYP2D6 CYP2C_5_04
Z_2_03 Verified Molecular Biology

Z_2_03 — Pharmacogenomics & Ethnobotanical Genetics

Pharmacogenomics — the study of how genetic variation affects drug response — has revealed that enzymes governing drug metabolism, particularly the cytochrome P450 (CYP) superfamily, show extraordinary population-specifi

pharmacogenomics ethnobotany CYP2D6 cytochrome P450 drug metabolism traditional medicine
Z_2_08 Verified Molecular Biology

Z_2_08 — Prion Genetics and Misfolded Proteins

Prions are infectious agents composed entirely of misfolded protein — the only known pathogen that contains no nucleic acid (no DNA, no RNA). The protein-only hypothesis (Stanley Prusiner, 1982 — Nobel Prize 1997) states

prion PRNP PrP PrPSc PrPC prion diseases
Z_2_09 Verified Molecular Biology

Z_2_09 — Mitochondrial Genetics and Diseases

Human mitochondrial DNA (mtDNA) is a 16,569-bp circular genome encoding 37 genes: 13 proteins (all subunits of the oxidative phosphorylation/OXPHOS complexes I, III, IV, and V), 22 transfer RNAs, and 2 ribosomal RNAs. Un

mitochondrial genetics mtDNA mitochondrial DNA mitochondrial disease oxidative phosphorylation OXPHOS
Z_2_04 Verified Molecular Biology

Z_2_04 — Genetic Disorders and Inborn Errors of Metabolism

Genetic disorders — diseases caused by mutations in single genes (monogenic) or chromosomal abnormalities — affect ~3–5% of live births and collectively represent thousands of distinct conditions catalogued in the Online

genetic disorder inborn error metabolism Mendelian disease sickle cell cystic fibrosis
Z_2_06 Credible Molecular Biology

Z_2_06 — Nutrigenomics and Diet-Gene Interactions

Nutrigenomics — the study of how genetic variation influences nutritional requirements, dietary responses, and disease susceptibility — and its complement nutrigenetics (how diet influences gene expression) represent a r

nutrigenomics nutrigenetics diet-gene interaction lactase persistence alcohol metabolism folate metabolism
Z_2_14 Verified Molecular Biology

Z_2_14 — Genetics of Longevity and Blue Zones

The genetics of human longevity — why some individuals live past 100 while most do not — is a field where heritability is modest, effect sizes are small, and environmental factors dominate, yet several genetic pathways h

longevity genetics aging centenarians Blue Zones telomeres telomerase
Z_2_11 Verified Molecular Biology

Z_2_11 — Genetics of Immunity and MHC Diversity

The major histocompatibility complex (MHC) — known as the human leukocyte antigen (HLA) system in humans — is the most polymorphic gene region in the human genome, encoding cell-surface glycoproteins essential for adapti

major histocompatibility complex MHC HLA human leukocyte antigen adaptive immunity antigen presentation
Z_2_22 Verified Molecular Biology

Z_2_22 — Telomere Molecular Biology

Telomeres are the protective nucleoprotein structures capping the ends of linear eukaryotic chromosomes, consisting of tandem repetitive DNA sequences (5'-TTAGGG-3' in vertebrates, repeating ~1,000–2,000 times for a tota

telomere telomerase chromosome end TTAGGG Hayflick limit replicative senescence
Z_2_02 Verified Molecular Biology

Z_2_02 — Telomere Biology & Genetics of Aging

Telomeres — repetitive DNA sequences (TTAGGG)ₙ capping the ends of linear chromosomes — serve as protective buffers against chromosome degradation, end-to-end fusion, and the progressive DNA loss inherent in the end-repl

telomere telomerase aging senescence Hayflick limit Elizabeth Blackburn
Z_2_07 Verified Molecular Biology

Z_2_07 — Genetics of Disease Resistance

Infectious disease has been the most powerful selective force shaping the human genome, leaving signatures across thousands of loci. The best-understood example is sickle cell disease (HbS, Glu6Val in HBB): heterozygous

disease resistance natural selection pathogen-driven selection sickle cell malaria resistance HbS
Z_2_05 Verified Molecular Biology

Z_2_05 — Gene Therapy: History and Progress

Gene therapy — the introduction, alteration, or replacement of genetic material within a patient's cells to treat or cure disease — has evolved from a speculative concept to an approved clinical reality over five decades

gene therapy gene replacement viral vector adeno-associated virus AAV lentivirus
Z_1_06 Verified Molecular Biology

Z_1_06 — Sex Determination Genetics

Sex determination — the biological process that establishes whether an organism develops as male, female, or an alternative reproductive type — employs remarkably diverse mechanisms across the tree of life. In placental

sex determination sex chromosomes X chromosome Y chromosome SRY gene X-inactivation
Z_1_08 Verified Molecular Biology

Z_1_08 — Transposons and Mobile Genetic Elements

Transposable elements (TEs, transposons) — segments of DNA that can move or copy themselves to new genomic locations — are among the most abundant and influential components of eukaryotic genomes. Discovered by Barbara M

transposon mobile genetic element transposable element jumping gene Barbara McClintock retrotransposon
Z_1_16 Verified Molecular Biology

Z_1_16 — Transposable Elements: Jumping Genes and Genome Evolution

Transposable elements (TEs) — sequences of DNA capable of moving ("jumping") from one genomic location to another — constitute approximately 45% of the human genome and up to 85% of the maize genome, making them the sing

transposable elements jumping genes Barbara McClintock retrotransposons DNA transposons Alu elements
Z_1_18 Verified Molecular Biology

Z_1_18 — Junk DNA & the ENCODE Controversy: Function, Noise, and the Human Genome

The term "junk DNA" — coined by Susumu Ohno (1972) to describe non-coding DNA sequences in eukaryotic genomes that appeared to have no functional role — ignited one of the most contentious debates in modern genomics: how

junk DNA ENCODE non-coding DNA transposable elements selfish DNA C-value paradox
Z_1_03 Verified Molecular Biology

Z_1_03 — Human Genome Project and Its Legacy

The Human Genome Project (HGP), launched in 1990 and completed in 2003, was the largest coordinated biological research effort in history — a $3 billion, 13-year international collaboration to sequence all ~3.2 billion b

Human Genome Project HGP genome sequencing Francis Collins Craig Venter Celera
Z_1_10 Verified Molecular Biology

Z_1_10 — Chromosome Evolution and Karyotype

Karyotype — the number, size, and morphology of chromosomes in a cell — varies enormously across species, from n=1 in the ant Myrmecia pilosula to n=630 in the fern Ophioglossum reticulatum. Humans have 2n=46 (23 pairs),

chromosome evolution karyotype chromosome number Robertsonian translocation chromosome fusion human chromosome 2
Z_1_12 Verified Molecular Biology

Z_1_12 — Genome Architecture and 3D Organization

The human genome — approximately 6.4 billion base pairs of DNA — is packed into a nucleus only ~6 μm in diameter. If stretched end-to-end, the DNA of a single human cell would extend about 2 meters, yet it is packaged an

genome architecture 3D genome chromatin organization topologically associating domains TADs chromosome territories
Z_1_11 Verified Molecular Biology

Z_1_11 — Polyploidy and Genome Duplication

Polyploidy — the possession of more than two complete sets of chromosomes — is a major force in genome evolution, particularly in plants and some animal lineages. Susumu Ohno (1970) proposed that whole genome duplication

polyploidy genome duplication whole genome duplication WGD autopolyploidy allopolyploidy